23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
23-Valent Pneumococcal Polysaccharide Vaccine Market aims to provide a comprehensive presentation of the global market for 23-Valent Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 23-Valent Pneumococcal Polysaccharide Vaccine. 23-Valent Pneumococcal Polysaccharide Vaccine Market contains market size and forecasts of 23-Valent Pneumococcal Polysaccharide Vaccine in global, including the following market information:
- Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five 23-Valent Pneumococcal Polysaccharide Vaccine companies in 2022 (%)
The global 23-Valent Pneumococcal Polysaccharide Vaccine market was valued at US$ 1172.5 million in 2022 and is projected to reach US$ 2261.4 million by 2029, at a CAGR of 9.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.
We surveyed the 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, by Type, 2022 (%)
- Single Dose Vial
- Pre-filled Syringe
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, by Application, 2022 (%)
- For Children (Over 2 Years Old)
- For Adult
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies 23-Valent Pneumococcal Polysaccharide Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies 23-Valent Pneumococcal Polysaccharide Vaccine revenues share in global market, 2022 (%)
- Key companies 23-Valent Pneumococcal Polysaccharide Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies 23-Valent Pneumococcal Polysaccharide Vaccine sales share in global market, 2022 (%)
- Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Sinovac
- Kangtai Bio
- CDIBP
- Walvax
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of 23-Valent Pneumococcal Polysaccharide Vaccine, market overview.
- Chapter 2: Global 23-Valent Pneumococcal Polysaccharide Vaccine market size in revenue and volume.
- Chapter 3: Detailed analysis of 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of 23-Valent Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global 23-Valent Pneumococcal Polysaccharide Vaccine capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
Industry Market Size
